Regulation of interleukin 2 receptors on T cells from multiple sclerosis patients
- PMID: 3085102
- PMCID: PMC323354
- DOI: 10.1073/pnas.83.8.2637
Regulation of interleukin 2 receptors on T cells from multiple sclerosis patients
Abstract
Receptors for interleukin 2 (IL-2) are absent on resting T lymphocytes and are induced by antigenic and mitogenic stimulation. After a limited time (8-12 days), these receptors on normal T cells are down-regulated despite the presence of receptor-saturating concentrations of IL-2. We report here that both antigen- and mitogen-induced T-cell lines and clones obtained from peripheral blood and cerebrospinal fluid of multiple sclerosis patients show prolonged expression of IL-2 receptors. This expression is coincident with a prolonged responsiveness to the proliferative effects of IL-2. In addition, Leu 3+, IL-2 receptor-positive T-cell clone from the cerebrospinal fluid of a multiple sclerosis patient has been established and maintained for more than 1 year without IL-2. This clone has some morphologic and histochemical properties of T cells transformed or infected by human T-lymphotropic virus type I.
Similar articles
-
The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.J Immunol. 1985 Jul;135(1):672-8. J Immunol. 1985. PMID: 3923116
-
Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis.J Immunol. 1987 Jul 1;139(1):68-72. J Immunol. 1987. PMID: 2438352
-
The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.Clin Exp Immunol. 1985 Aug;61(2):248-56. Clin Exp Immunol. 1985. PMID: 3930109 Free PMC article.
-
Two pathways of T cell activation.Behring Inst Mitt. 1987 Jun;(81):15-30. Behring Inst Mitt. 1987. PMID: 3115246 Review.
-
T cell activation antigens: therapeutic implications.Immunol Invest. 1987-1988 Dec;16(8):687-723. doi: 10.3109/08820138709087109. Immunol Invest. 1987. PMID: 2839414 Review. No abstract available.
Cited by
-
Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1.J Virol. 1989 Aug;63(8):3257-60. doi: 10.1128/JVI.63.8.3257-3260.1989. J Virol. 1989. PMID: 2526228 Free PMC article.
-
Relative increase of inflammatory CD4+ T cells in the cerebrospinal fluid of multiple sclerosis patients and control individuals.Clin Exp Immunol. 1990 Jan;79(1):15-20. doi: 10.1111/j.1365-2249.1990.tb05120.x. Clin Exp Immunol. 1990. PMID: 1967993 Free PMC article.
-
Lymphocyte activating factor activity in the serum and cerebrospinal fluid of patients with multiple sclerosis.Ital J Neurol Sci. 1990 Feb;11(1):21-9. doi: 10.1007/BF02334901. Ital J Neurol Sci. 1990. PMID: 2332322
-
The interleukins in acquired disease.Clin Exp Immunol. 1988 Nov;74(2):151-61. Clin Exp Immunol. 1988. PMID: 3066538 Free PMC article. Review. No abstract available.
-
Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system.J Exp Med. 1987 Apr 1;165(4):1058-75. doi: 10.1084/jem.165.4.1058. J Exp Med. 1987. PMID: 2435831 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical